Advertisement

Experimental models of aluminum toxicity

  • Norman C. Blumenthal
  • John C. Grew
Chapter
Part of the Developments in Nephrology book series (DINE, volume 26)

Abstract

While the clinical ramifications of aluminum toxicity are well known and have recently been well documented, many of the underlying causes for these toxic effects are unknown. In order to understand the bases of these clinically-observed symptoms, experimental systems have been designed and studied which have attempted to approximate some of the effects of aluminum in the human body. These model systems have typically been designed to study the effects of aluminum on skeletal and central nervous system tissues, as well as to investigate aluminum metabolism and turnover. Further, such endeavors may be grouped into two experimental genre: Physical-chemical and biological studies.

Keywords

Aluminum Toxicity Renal Osteodystrophy Radial Distribution Function Dialysis Encephalopathy Bone Cell Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Thomas WC, Jr., 1982: Trace metal-citric acid complexes as inhibitors of calcification and crystal formation. Proc Soc Exp Biol Med 170: 321.PubMedGoogle Scholar
  2. 2.
    Meyer JL, Thomas WC Jr., 1982: Inhibition of calcium phosphate crystal growth by trace metal-citric acid complexes: The Al(III)-, Cr(III)-, and Fe(III)-citric acid system. J Urol 128: 1372.PubMedGoogle Scholar
  3. 3.
    Meyer JL, Thomas WC Jr., 1986: Aluminum and aluminum complexes: Effect on calcium phosphate precipitation. Kidney Int 29 (Suppl.): S20.Google Scholar
  4. 4.
    Blumenthal NC, Posner AS, 1984: In vitro model of aluminum-induced osteomalacia: Inhibition of hydroxy apatite formation and growth. Calcif Tissue Int 36: 439.Google Scholar
  5. 5.
    Blumenthal NC, 1985: Binding of aluminum to hydroxyapatite and amorphous calcium phosphate as a model for aluminum-associated osteomalacia. The Chemistry & Biology of Mineralized Tissues. WT Butler, Ed., EBSCO Media, Birmingham, pp. 385 - 88.Google Scholar
  6. 6.
    Posner AS, Blumenthal NC, Boskey AL, 1986: Model of aluminum-induced osteomalacia: Inhibition of apatite formation and growth. Kidney Int 29 (Suppl.): S17.Google Scholar
  7. 7.
    Posner AS, Betts F, Blumenthal NC, 1979: Bone mineral composition and structure. Skeletal Research: An experimental approach. DJ Simmons & AS Kunin, Eds., Academic Press, New York. Vol. 1, pp. 167–92.Google Scholar
  8. 8.
    Gorsky JE, Deitz AA, 1978: Determination of aluminum in biological samples by atomic absorption spectrometry with a graphite furnace. Clin Chem 24: 1485.PubMedGoogle Scholar
  9. 9.
    Alderman FR, Gitelman HJ, 1980: Improved electrothermal determination of aluminum in serum by atomic absorption spectroscopy. Clin Chem 26: 258.PubMedGoogle Scholar
  10. 10.
    Gardener PE, Ottaway JM, Fell GS, Hall DJ, 1981: Determination of aluminum in blood plasma or serum by electrothermal atomic absorption spectrometry. Anal Chim Acta 116: 57.CrossRefGoogle Scholar
  11. 11.
    Oster O, 1981: The aluminum content of human serum determined by atomic absorption spectroscopy with a graphite furnace. Clin Chim Acta 114: 53.PubMedCrossRefGoogle Scholar
  12. 12.
    Gitelman HJ, Alderman FR, 1986: Electrothermal determination of aluminum in biological samples by atomic absorption spectroscopy. Kidney Int 29: S28.Google Scholar
  13. 13.
    Smith PS, J McClure, 1982: Localisation of aluminum by histochemical and electron probe X-ray microanalytical techniques in bone tissue of cases of renal osteodystrophy. J Clin Pathol 35: 1283.PubMedCrossRefGoogle Scholar
  14. 14.
    Smith DM Jr., Pitcock JA, Murphy WM, 1982: Aluminum-containing dense deposits of the glomerular basement membrane: Identification by energy-dispersive X-ray analysis. Am J Clin Pathol 77: 341.Google Scholar
  15. 15.
    Perl DP, Gadjusek DC, Garrutto RM, Yanagihara RT, Gibbs CJ Jr., 1982: Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science 217: 1053.PubMedCrossRefGoogle Scholar
  16. 16.
    Hodsman AB, Sherrard DJ, Alfrey AC, Ott S, Brickman AS, Miller NL, Maloney NA, Coburn JW, 1982: Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab 54: 539.PubMedCrossRefGoogle Scholar
  17. 17.
    Chan Y-L, Alfrey Ac, Posen S, Lissner D, Hills E, Dunstan CR, Evans RA, 1983: Effect of aluminum on normal and uremic rats: Tissue distribution, vitamin D metabolites, and quantitative bone histology. Calcif Tissue Int 35: 344.Google Scholar
  18. 18.
    Robertson JA, Felsenfeld JA, Haygood CC, Wilson P, Clarke C, Llach F, 1983: Animal model of aluminum-induced osteomalacia: Role of chronic renal failure. Kidney Int 23: 327.Google Scholar
  19. 19.
    Faugere MC, Arnala IO, Ritz E, Malluche HH, 1986: Loss of bone resulting from accumulation of aluminum in bone of patients undergoes dialysis. J Lab Clin Med 107: 481.PubMedGoogle Scholar
  20. 20.
    O’Connor MO, Garrett P, Dockery M, Donohoe JF, Doyle GD, Carmody M, Dervan PA, 1986: Aluminum-related bone disease: Correlation between symptoms, osteoid volume, and aluminum staining. AJCP 86: 168.Google Scholar
  21. 21.
    Smith AJ, Faugere M-C, Abreo K, Fanti P, Julian B, Malluche HH, 1986: Aluminum- related bone disease in mild and advanced renal failure: Evidence for high prevalence and morbidity and studies on etiology and diagnosis. Am J Nephrol 6: 275.Google Scholar
  22. 22.
    Ellis HA, McCarthy JH, Herrington J, 1979: Bone aluminum in haemodyalised patients and in rats injected with aluminum chloride: Relationship to impaired bone mineralisation. J Clin Pathol 32: 832.Google Scholar
  23. 23.
    Goodman WG, 1984: Short-term aluminum administration in the rat: Reductions in bone formation without osteomalacia, J Lab Clin Med 103: 749.PubMedGoogle Scholar
  24. 24.
    Goodman WG, Gilligan J, Horst R, 1984: Short-term aluminum administration in the rat: Effects on bone formation and relationship to renal osteomalacia. J Clin Invest 73: 171.Google Scholar
  25. 25.
    Henry DA, Goodman WG, Nudelman RK, DiDomenico NC, Alfrey AC, Slatopolsky E, Stanley TM, Coburn JW, 1984: Parenteral aluminum administration in the dog: I. Plasma kinetics, tissue levels, calcium metabolism, and parathyroid hormone. Kidney Int 25: 362.PubMedCrossRefGoogle Scholar
  26. 26.
    Goodman WG, Henry DA, Horst R, Nudelman RK, Alfrey AC, Coburn JW, 1984: Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism. Kidney Int 25: 370–75.PubMedCrossRefGoogle Scholar
  27. 27.
    Goodman WG, 1985: The differential response of cortical and trabecular bone to aluminum administration in the rat. Proc Soc Exp Biol Med 179: 509.PubMedGoogle Scholar
  28. 28.
    Berlyne GM, Yagil R, Ben-Ari J, Weinberger G, Knopf E, Danovitch GM, 1972: Alumi¬num toxicity in rats. Lancet (ii): 564.Google Scholar
  29. 29.
    Ihle BU, Becker GJ, Kincaid-Smith PS, 1986: Clinical and biological features of aluminum- related bone disease. Kidney Int 29 (Suppl): S80.CrossRefGoogle Scholar
  30. 30.
    Berlyne GM, Pest D, Ben-Ari J, Weinberger J, Stern M, Gilmore GR, Levine R, 1970: Hyperaluminemia from aluminum resins in renal failure. Lancet (ii): 494.Google Scholar
  31. 31.
    Verbueken AH, Van der Vyer FL, Van Gricken RE, Paulus GJ, Visser WJ, D’Haese P, DeBroe ME, 1984: Ultrastructural localization of aluminum in patients with dyalisis- associated osteomalacia. Clin Chem 30: 763.PubMedGoogle Scholar
  32. 32.
    DeBroe ME, Van der Vyer FL, Bekaert AB, D’Haese P, Paulus GJ, Visser WJ, Van Grieken R, DeWolff FA, Verbueken AH, 1984: Correlation of serum aluminum values with tissue aluminum concentrations. Contr Nephrol 38: 37.Google Scholar
  33. 33.
    Krishnan SS, Gillespe KA, Crapper DR, 1972: Determination of aluminum in biological material by atomic absorption spectrophotometry. Anal Chem 44: 1469.PubMedCrossRefGoogle Scholar
  34. 34.
    Mayor GH, Sprague SM, Hourani MR, Sanchez TV, 1980: Parathyroid hormone-mediated aluminum and egress in the rat. Kidney Int 17: 40.PubMedCrossRefGoogle Scholar
  35. 35.
    Rodriquez M, Felsenfeld AJ, Llach F, 1987: The role of aluminum in the development of hypercalcemia in the rat. Kidney Int 31: 766.CrossRefGoogle Scholar
  36. 36.
    Milne FJ, Sharf B, Bell P, Meyers AM, 1983: The effect of low aluminum water and desferoxamine on the outcome of dialysis encephalopathy. Clin Nephrol 20: 202.PubMedGoogle Scholar
  37. 37.
    Malluche HH, Smith AJ, Abreo K, Faugere M, 1984: The use of desferoxamine in the management of aluminum accumulation in bone of patients with renal failure. N Engl J Med 311: 140.PubMedCrossRefGoogle Scholar
  38. 38.
    Cain JM, Luck VA, Eastwood JB, DeWardener HE, 1976: The effect of aluminum hydroxide orally on calcium, phosphorus and aluminum metabolism in normal subjects. Clin Sci Mol Med 51: 407.Google Scholar
  39. 39.
    Kaehny WD, Hegg AP, Alfrey AC, 1977: Gastrointestinal absorption of aluminum- containing antacids. N Engl J Med 296: 1389.PubMedCrossRefGoogle Scholar
  40. 40.
    Mayor GH, Keiser JA, Makadani D, Ku PK, 1977: Aluminum absorption and distribution: Effect of parathyroid hormone. Science 197: 1187.Google Scholar
  41. 41.
    Gorsky JE, Deitz AA, Spencer H, Osis D, 1979: Metabolic balance of aluminum studied in six men. Clin Chem 25: 1739.PubMedGoogle Scholar
  42. 42.
    Feinroth M, Feinroth MV, Berlyne GM, 1982: Aluminum absorption in the rat everted gut sac. Mineral Electrolyte Metab 8: 29 - 35.Google Scholar
  43. 43.
    Irwin DA, 1955: The demonstration of aluminum in animal tissues. Archives of Industrial Health 12: 218.Google Scholar
  44. 44.
    Pearse AGE, 1972: Histochemistry: Theoretical and applied. Churchill-Livingstone, Lon¬don. Vol. 2, pp. 1406 - 08.Google Scholar
  45. 45.
    Maloney NA, Ott SM, Alfrey AC, Miller NL, Coburn JW, Sherrard DJ, 1982: Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med 99: 206.PubMedGoogle Scholar
  46. 46.
    Denton J, Freemont AJ, Ball J, 1984: Detection and distribution of aluminum in bone. J Clin Pathol 37: 136.PubMedCrossRefGoogle Scholar
  47. 47.
    Visser WJ, Van de Vyver FL, Verbueken AH, D’Haese P, Bekaert AB, Van Grieken RA, Duurmsa SA, DeBroe ME, 1985: Evaluation of different techniques to determine aluminum in patients with chronic renal failure. Metals in Bone. ND Priest, Ed., MTP Press, Ltd., Lancaster, pp. 433 - 41.Google Scholar
  48. 48.
    Verbueken AH, Van de Vyver FL, Visser WJ, Van Grieken RE, DeBroe ME, 1986: Laser microprobe analysis ( LAMMA) to verify the aluminon staining of bone. Stain Technology 61: 287.Google Scholar
  49. 49.
    Goodman WG, 1987: Thyroparathyroidectomy modifies the skeletal response to aluminum loading in the rat. Kidney Int 31: 923.PubMedCrossRefGoogle Scholar
  50. 50.
    Plachot J-J, Cournot-Witmer G, Halpern S, Mendez V, Bourdeau A, Fritsch J, Bourdon R, Drueke T, Galle P, Balsan S, 1984: Bone ultrastructure and X-ray microanalysis of aluminum-intoxicated hemodialyzed patients. Kidney Int 25: 796.PubMedCrossRefGoogle Scholar
  51. 51.
    Alfrey AC, LeGendre GR, Kaehny WD. The dialysis encephalopathy syndrome: Possible aluminum intoxication. N Engl J Med 294: 184.Google Scholar
  52. 52.
    McDermott JR, Smith AI, Ward MK, Fawcett RWP, Kerr DNS, 1978: Brain-aluminum concentration in dyalysis encephalopathy. Lancet (i): 901.Google Scholar
  53. 53.
    Alfrey AC, 1986: Dialysis encephalopathy. Kidney Int 29 (Suppl.): S53.Google Scholar
  54. 54.
    Terai M, Hata S, Nishii Y, 1977: An application of activation analysis of aluminum in biological materials. Radioanal Chem 37: 599.CrossRefGoogle Scholar
  55. 55.
    Garmestani K, Blotcky AJ, Rack EP, 1978: Comparison between neutron activation analysis and graphite furnace atomic absorption spectrometry for trace aluminum determination in biological materials. Anal Chem 50: 144.PubMedCrossRefGoogle Scholar
  56. 56.
    Blotcky AJ, Hobson D, Leffler JA, Rack EP, Recker RR, 1976: Determination of trace aluminum in urine by neutron activation analysis. Anal Chem 48: 1084.PubMedCrossRefGoogle Scholar
  57. 57.
    Malluche HH, Sherman D, Meyer W, Massry SG, 1982: A new semi-method for quantitative static and dynamic bone histology. Calcif Tissue Int 34: 439.PubMedCrossRefGoogle Scholar
  58. 58.
    Malluche HH, Meyer W, Sherman D, Massry SG, 1982: Quantitative bone histology in 84 normal American subjects. Calcif Tissue Int 34: 449.PubMedCrossRefGoogle Scholar
  59. 59.
    Llach F, Felsenfeld AJ, Cloeman MD, Keaveney JJ Jr., Pederson JA, Medlock TR, 1986: The natural course of dialysis osteomalacia. Kidney Int 29: S74.Google Scholar
  60. 60.
    Lieberherr M, Grosse B, Cournot-Witmer G, Thil CL, Balsan S, 1982: In vitro effects of aluminum on bone phosphatases: A possible interaction with bPTH and vitamin D3 metabolites. Calcif Tissue Int 34: 280.PubMedCrossRefGoogle Scholar
  61. 61.
    Lieberherr M, Grosse B, Cournot-Witmer G, Hermann-Erlee MPM, Balsan S, 1987: Aluminum action on mouse bone cell metabolism and response to PTH and 1, 25(OH)2D3. Kidney Int 31: 736.Google Scholar
  62. 62.
    O’Hare JA, Murnahagn DJ, 1984: Evidence of increased parathyroid activity on discontinuation of high-aluminum dialysate in patients undergoing hemodialysis. Am J Med 77: 229.PubMedCrossRefGoogle Scholar
  63. 63.
    Talwar HS, Hari-Reddi A, Menczel J, Thomas WC Jr., Meyer JL, 1986: Influence of aluminum on mineralization during matrix-induced bone development. Kidney Int 29: 1038.PubMedCrossRefGoogle Scholar
  64. 64.
    Cann CE, Prussin SG, Gordan GS, 1979: Aluminum uptake by the parathyroid glands. J Clin Endocinol Metab 49: 543.CrossRefGoogle Scholar
  65. 65.
    Morrissey J, Rothstein M, Mayor G, Slatopolsky E, 1983: Suppression of parathyroid hormone secretion by aluminum. Kidney Int 23: 699.PubMedCrossRefGoogle Scholar
  66. 66.
    Morrissey J, Slatopolsky E, 1986, Effect of aluminum on parathyroid hormone secretion. Kidney Int 29 (Suppl.): S41.CrossRefGoogle Scholar
  67. 67.
    Kawaguchi Y, Oda Y, Imamamura N, Shigematu T, Kimura Y, Aizaw S, Fujimaki H, Shoji R, Tsukui I, Ogura Y, Miyahara T, 1986: Unresponsiveness of bone to PTH in aluminum- related renal osteomalacia. Kidney Int 29 (Suppl.): S49.Google Scholar

Copyright information

© Kluwer Academic Publishers 1990

Authors and Affiliations

  • Norman C. Blumenthal
  • John C. Grew

There are no affiliations available

Personalised recommendations